# Emothion (S-Acetyl Glutathione)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/emothion
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** S-acetyl-L-glutathione, S-acetyl glutathione, Acetylated glutathione, SAG, S-acetylglutathione, N-acetyl-S-glutathione

## Overview

Emothion is a stabilized, acetylated form of [glutathione](/ingredients/condition/detox) (S-Acetyl Glutathione) in which an acetyl group is bonded to the sulfur atom of the cysteine residue, protecting it from oxidation and gastrointestinal degradation. Once absorbed, intracellular deacetylases cleave the acetyl group, releasing free reduced glutathione (GSH) directly inside cells to support [antioxidant](/ingredients/condition/antioxidant) defense and redox balance.

## Health Benefits

• Enhanced oral [glutathione](/ingredients/condition/detox) bioavailability: One crossover trial in 18 healthy volunteers showed superior plasma GSH elevation compared to standard glutathione (evidence: preliminary clinical)
• Cellular antioxidant support: Replenishes intracellular glutathione for [free radical](/ingredients/condition/antioxidant) defense and redox balance (evidence: mechanistic/theoretical)
• [Mitochondrial function](/ingredients/condition/energy) support: Maintains GSH levels for mitochondrial action and enzyme maintenance (evidence: mechanistic/theoretical)
• Potential [antiviral](/ingredients/condition/immune-support) activity: Preclinical studies suggest anti-HSV-1 activity (evidence: preliminary/in-vitro only)
• Apoptosis modulation: Laboratory studies indicate potential for inducing programmed cell death (evidence: preliminary/in-vitro only)

## Mechanism of Action

S-Acetyl [Glutathione](/ingredients/condition/detox) resists hydrolysis by gastrointestinal peptidases that normally degrade unmodified glutathione, enabling intact intestinal absorption via passive diffusion. Inside cells, cytosolic thioesterases and deacetylase enzymes remove the acetyl moiety, regenerating reduced glutathione (GSH), which then serves as a cofactor for glutathione peroxidase (GPx) and glutathione S-transferase (GST) to neutralize [reactive oxygen species](/ingredients/condition/antioxidant) and detoxify electrophilic compounds. This intracellular GSH replenishment also supports the thioredoxin system and maintains the GSH/GSSG redox ratio, a critical regulator of cellular oxidative stress signaling.

## Clinical Summary

A randomized crossover trial in 18 healthy volunteers demonstrated that oral S-Acetyl [Glutathione](/ingredients/condition/detox) supplementation produced significantly greater increases in plasma GSH levels compared to unmodified glutathione at equivalent doses, though absolute figures varied by dose and duration. Preclinical studies in cell culture models have confirmed intracellular GSH elevation following S-Acetyl Glutathione treatment, with measurable reductions in markers of [oxidative stress](/ingredients/condition/antioxidant) such as malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Overall, the human clinical evidence base remains preliminary, consisting primarily of small, short-duration trials, and larger randomized controlled trials with standardized dosing protocols are needed to confirm therapeutic efficacy. Current evidence supports bioavailability superiority over standard glutathione but stops short of establishing definitive clinical outcomes for disease endpoints.

## Nutritional Profile

S-Acetyl [Glutathione](/ingredients/condition/detox) (SAG) is a thioester derivative of the tripeptide L-glutathione (γ-L-glutamyl-L-cysteinyl-glycine) with an acetyl group attached to the sulfhydryl moiety of the cysteine residue, yielding the molecular formula C₁₂H₁₉N₃O₇S (MW ~349.36 g/mol). Typical supplement doses range from 100–300 mg per serving. Unlike reduced glutathione (GSH), the acetyl group protects the thiol from oxidative degradation in the GI tract and enhances lipophilicity, allowing superior intestinal absorption and intracellular delivery. Once absorbed, intracellular thioesterases cleave the acetyl group to liberate free reduced glutathione. Contains no meaningful macronutrients (protein, fat, carbohydrate, fiber) or caloric value at supplemental doses. No vitamins or minerals are inherently present unless added by the formulator. The constituent amino acids (glutamate, cysteine, glycine) are present in peptide-bound form at stoichiometric ratios (~1:1:1 molar). The cysteine-derived sulfur (~9.2% by molecular weight) serves as the functional thiol donor critical for redox activity. Bioavailability notes: Oral bioavailability is substantially higher than standard reduced L-glutathione, which is extensively degraded by gastric acid, intestinal peptidases (γ-glutamyltransferase), and first-pass hepatic [metabolism](/ingredients/condition/weight-management). A crossover pharmacokinetic study in 18 healthy volunteers demonstrated that S-acetyl glutathione produced significantly greater plasma GSH area-under-the-curve (AUC) compared to equimolar unacetylated GSH. The acetylated form resists hydrolysis by GGT in the intestinal brush border, passes intact through enterocytes, and is deacetylated intracellularly by cytoplasmic esterases and acylases. Its enhanced lipophilicity (higher logP than reduced GSH) facilitates passive transcellular absorption. Stability is markedly improved at gastric pH (pH 1.5–3.5) compared to reduced GSH, which rapidly oxidizes to GSSG. No significant food-drug interaction data specific to SAG; however, co-administration with N-acetylcysteine or selenium (as selenomethionine) may synergistically support glutathione peroxidase activity. The product is typically free of common allergens and is suitable for vegetarian/vegan use depending on capsule material.

## Dosage & Preparation

The bioavailability trial used a single oral dose of Emothion (exact mg not specified). Commercial products typically feature 300 mg capsules of crystalline Emothion standardized to ≥98% purity in acid-resistant formulations. No standardized daily dosage ranges have been established through multiple clinical studies. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

S-Acetyl Glutathione is generally well tolerated in short-term studies, with no serious adverse events reported at typical supplemental doses ranging from 100 mg to 300 mg per day. Mild gastrointestinal symptoms such as bloating or loose stools have been occasionally noted, consistent with other sulfur-containing compounds. Because glutathione can influence the activity of cytochrome P450 enzymes and [Phase II detox](/ingredients/condition/detox)ification pathways, theoretical interactions exist with chemotherapy agents such as platinum-based drugs, where elevated intracellular GSH may reduce cytotoxic efficacy. Safety data during pregnancy and lactation are insufficient, and use is not recommended in these populations without medical supervision.

## Scientific Research

Clinical evidence is limited to a single-center, randomized, open-label, two-sequence, two-period crossover trial comparing oral bioavailability of Emothion versus standard GSH in 18 healthy volunteers, showing superior plasma GSH elevation with SAG. No large-scale RCTs, meta-analyses, or published PMIDs for human efficacy trials were identified; therapeutic applications remain largely theoretical based on preclinical data.

## Historical & Cultural Context

No historical or traditional medicinal use exists for S-acetyl [glutathione](/ingredients/condition/detox), as it is a modern synthetic derivative developed via chemical acetylation for improved stability. While glutathione itself occurs naturally in animals, plants, and microbes, this acetylated form has no roots in traditional medicine systems.

## Synergistic Combinations

N-acetyl cysteine, alpha-lipoic acid, vitamin C, vitamin E, selenium

## Frequently Asked Questions

### What is the difference between S-Acetyl Glutathione and regular glutathione?

Regular glutathione is highly susceptible to degradation by gastrointestinal peptidases before it can be absorbed intact, resulting in poor oral bioavailability. S-Acetyl Glutathione has an acetyl group attached to the cysteine sulfur atom, shielding it from enzymatic breakdown so it can be absorbed intact and converted to free GSH inside cells by intracellular deacetylases. A crossover trial in 18 volunteers confirmed plasma GSH elevations were significantly greater with S-Acetyl Glutathione than with standard glutathione at equivalent oral doses.

### What is the recommended dosage of S-Acetyl Glutathione?

Clinical and commercial protocols typically use doses ranging from 100 mg to 300 mg per day of S-Acetyl Glutathione, often taken once daily on an empty stomach to optimize absorption. The crossover trial demonstrating superior bioavailability used doses within this range, though an optimal evidence-based dose has not yet been formally established in large-scale trials. Individuals should consult a healthcare provider before exceeding 300 mg daily, as high-dose long-term safety data are limited.

### How long does it take for S-Acetyl Glutathione to raise glutathione levels?

Measurable increases in plasma reduced glutathione (GSH) have been detected within hours of a single dose in pharmacokinetic studies, reflecting relatively rapid intestinal absorption and intracellular conversion. Sustained elevation of tissue GSH levels in short-term supplementation trials has been observed over periods of two to four weeks of daily use. However, individual response varies based on baseline GSH status, oxidative stress burden, and metabolic factors such as cysteine availability.

### Can S-Acetyl Glutathione interact with chemotherapy drugs?

There is a clinically relevant concern that elevated intracellular glutathione levels could reduce the efficacy of platinum-based chemotherapy agents such as cisplatin and carboplatin, which rely partly on oxidative mechanisms to induce cancer cell apoptosis. GSH conjugates and inactivates these electrophilic drugs through glutathione S-transferase activity, potentially diminishing cytotoxic effects. Patients undergoing chemotherapy should not use S-Acetyl Glutathione or any glutathione-boosting supplement without explicit approval from their oncologist.

### Is S-Acetyl Glutathione safe for long-term use?

Short-term use of S-Acetyl Glutathione at doses up to 300 mg per day appears well tolerated based on available trial data, with side effects largely limited to mild gastrointestinal discomfort in some users. Long-term safety data beyond several months are lacking, as no large, multi-year controlled studies have been published to date. Theoretical concerns include potential suppression of endogenous GSH synthesis through negative feedback if exogenous intake is chronically high, though this has not been demonstrated clinically.

### Does Emothion (S-Acetyl Glutathione) need to be taken with food or on an empty stomach?

S-Acetyl Glutathione can be taken with or without food, though taking it with a light meal may enhance absorption and reduce potential gastrointestinal sensitivity. The acetylation modification makes this form more stable in the digestive tract compared to unmodified glutathione, allowing more flexibility in timing. Individual tolerance may vary, so consistent daily timing is more important than the specific meal context.

### Who would benefit most from S-Acetyl Glutathione supplementation?

Individuals with elevated oxidative stress, poor dietary glutathione intake, aging adults seeking antioxidant support, and those recovering from intense physical training or environmental exposures may benefit most from this form. People with compromised glutathione levels due to chronic stress, poor nutrition, or certain health conditions are also candidates, though medical consultation is recommended. Athletes and individuals in high-demand cognitive or physical occupations may find value in the cellular energy and redox support it provides.

### What does current clinical research show about Emothion's effectiveness compared to other glutathione supplements?

A crossover trial in 18 healthy volunteers demonstrated that S-Acetyl Glutathione produces superior plasma glutathione elevation compared to standard glutathione supplementation, supporting its improved bioavailability. However, evidence remains preliminary and limited to small-scale clinical studies, with most mechanistic benefits supported by theoretical and in vitro research rather than large human trials. Additional long-term efficacy studies are needed to fully establish its clinical advantages over other glutathione forms in various populations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*